Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Nat Commun ; 15(1): 3916, 2024 May 10.
Artigo em Inglês | MEDLINE | ID: mdl-38729927

RESUMO

The UK observed a marked increase in scarlet fever and invasive group A streptococcal infection in 2022 with severe outcomes in children and similar trends worldwide. Here we report lineage M1UK to be the dominant source of invasive infections in this upsurge. Compared with ancestral M1global strains, invasive M1UK strains exhibit reduced genomic diversity and fewer mutations in two-component regulator genes covRS. The emergence of M1UK is dated to 2008. Following a bottleneck coinciding with the COVID-19 pandemic, three emergent M1UK clades underwent rapid nationwide expansion, despite lack of detection in previous years. All M1UK isolates thus-far sequenced globally have a phylogenetic origin in the UK, with dispersal of the new clades in Europe. While waning immunity may promote streptococcal epidemics, the genetic features of M1UK point to a fitness advantage in pathogenicity, and a striking ability to persist through population bottlenecks.


Assuntos
COVID-19 , Filogenia , Infecções Estreptocócicas , Streptococcus pyogenes , Streptococcus pyogenes/genética , Streptococcus pyogenes/patogenicidade , Streptococcus pyogenes/isolamento & purificação , Reino Unido/epidemiologia , Humanos , Infecções Estreptocócicas/epidemiologia , Infecções Estreptocócicas/microbiologia , COVID-19/epidemiologia , Pandemias , Escarlatina/epidemiologia , Escarlatina/microbiologia , Mutação , Proteínas Repressoras/genética , SARS-CoV-2/genética , SARS-CoV-2/isolamento & purificação , Genoma Bacteriano , Europa (Continente)/epidemiologia , Proteínas de Bactérias
2.
Epilepsia ; 43(9): 1096-100, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12199736

RESUMO

PURPOSE: Several studies attempted to clarify the genotype-phenotype correlations in patients with inverted duplication of chromosome 15 [inv dup(15)], which is usually characterized by severe mental retardation and epilepsy in individuals with large duplications including the Prader-Willi/Angelman region. We report two patients with inv dup(15) who, in spite of a large duplication, had a mild phenotype including adult-onset epilepsy. This report may help to define the milder spectrum of the syndrome. METHODS: A 25-year-old girl with mild mental retardation had a 6-year history of absence seizures, with occasional head drop. Interictal EEG revealed diffuse spike-wave complexes. Epilepsy was well controlled by a combination of lamotrigine (LTG) and valproate (VPA). The other patient, a 27-year-old man with mild mental retardation, had a 5-year history of rare generalized tonic-clonic seizure during sleep, and frequent episodes of unresponsiveness, which appeared to be atypical absence seizures on video-EEG recordings. A combination of VPA and LTG led to a remarkable improvement, although no complete control. RESULTS: Molecular analysis revealed a large inv dup15 in both patients. CONCLUSIONS: The discrepancy between the mild phenotype and the severe chromosomal abnormality detected in these two patients further supports the notion that the site of breakpoint might be contributory to the inv dup(15) phenotype. Inv dup(15) should be considered in atypical cases of generalized epilepsy of adult onset without clear-cut etiology.


Assuntos
Inversão Cromossômica , Cromossomos Humanos Par 15/genética , Epilepsia Generalizada/genética , Duplicação Gênica , Deficiência Intelectual/genética , Adulto , Idade de Início , Síndrome de Angelman/diagnóstico , Síndrome de Angelman/genética , Anticonvulsivantes/uso terapêutico , Aberrações Cromossômicas , Eletroencefalografia/estatística & dados numéricos , Epilepsia Tipo Ausência/diagnóstico , Epilepsia Tipo Ausência/tratamento farmacológico , Epilepsia Tipo Ausência/genética , Epilepsia Generalizada/diagnóstico , Epilepsia Generalizada/tratamento farmacológico , Feminino , Humanos , Hibridização in Situ Fluorescente , Lamotrigina , Masculino , Fenótipo , Síndrome de Prader-Willi/diagnóstico , Síndrome de Prader-Willi/genética , Índice de Gravidade de Doença , Resultado do Tratamento , Triazinas/uso terapêutico , Ácido Valproico/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA